Trial · NCT05266924
Recombinant Follicle-stimulating Hormone in Treatment for Infertility
NCT05266924, Phase 3, Unknown, Bharat Serums and Vaccines Limited
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Recombinant Follicle-stimulating Hormone in Treatment for Infertility. Trials, record NCT05266924. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05266924
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Recombinant Follicle-stimulating Hormone in Treatment for Infertility
- NCT number
- NCT05266924
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 250 participants, estimated
- Lead sponsor
- Bharat Serums and Vaccines Limited
- Conditions
- Female Infertility
- Interventions
- Recombinant Human Follicle Stimulating Hormone 900 IU (66.0 μg) / 1.5mL Solution for Injection in Prefilled Pen
- First posted
- 2022-03-04
- Last updated
- 2023-08-01
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of oocytes retrieved | Oocyte pick up - up to ~ 34 to 36 hours after human chorionic gonadotropin (hCG) administration | Number of oocytes retrieved |
| Secondary | Clinical pregnancy rate | 4 weeks after embryo transfer (ET) | Clinical pregnancy rate |
| Secondary | Ongoing Pregnancy rate | 11±1 weeks after ET | Ongoing pregnancy rate |
| Secondary | Cycle cancellation rate | at Stimulation phase up to 20 days, oocyte pick up up to ~ 34 to 36 hours after hCG administration, ET anytime up to 8 weeks | Cycle cancellation rate |
| Secondary | Total Doseof r-hFSH | at end of stimulation up to 20 days | Total dose of r-hFSH (in IU) required for ovarian stimulation; |
| Secondary | Number of Days of r-hFSH stimulation | at end of stimulation up to 20 days | Number of days of r-hFSH stimulation |
| Secondary | Number of subject Change in Dosage | post Day 6 till end of stimulation up to 20 days | Proportion of subjects requiring change in dose |
| Secondary | Hormonal Investigation | Day 6 | Estradiol, Luteinizing, Progesterone, and inhibin b levels |
| Secondary | Follicle size on Day 6 | Day 6 | Number of follicles with size \<11mm, Number of follicles with size 11- 14 mm, Number of follicles with size15 mm, Number of follicles with size16 mm, Number of follicles with size17 mm and Number of follicles with size ≥18 mm |
| Secondary | Follicle size at HCG administration | Day of hCG administration anytime upto 3 weeks | Number of follicles with size \<11mm, Number of follicles with size 11- 14 mm, Number of follicles with size15 mm, Number of follicles with size16 mm, Number of follicles with size17 mm and Number of follicles with size ≥18 mm mm) |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05266924
GET https://conductscience.org/api/trials/v1/NCT05266924/registered